Skip to content

PFE

Pfizer Inc.

Cash flow statement

Cash flow statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Operating cash flow14.2B11.7B12.7B8.7B29.3B32.6B14.4B12.6B15.8B16.8B16.2B14.7B17.1B17.7B16.7B20.2B11.5B16.6B18.2B13.4B
2.39B2.63B2.91B3.91B3.24B2.71B2.23B2.05B1.98B1.96B1.82B1.40B1.20B1.21B1.33B1.66B1.51B1.21B1.70B1.88B
Free cash flow11.8B9.1B9.8B4.8B26.0B29.9B12.2B10.5B13.8B14.8B14.4B13.3B15.9B16.5B15.4B18.6B9.9B15.4B16.5B11.5B
Depreciation and amortization6.50B6.59B7.01B6.29B5.06B5.19B4.68B5.76B6.38B6.27B5.76B5.16B5.54B6.31B7.39B8.70B8.40B4.76B5.09B5.20B
Stock-based compensation1.11B0.80B0.88B0.53B0.87B1.18B0.76B0.69B0.92B0.84B0.69B0.67B0.59B0.52B0.48B0.42B0.41B0.35B0.38B0.44B
Buybacks——002.0B008.9B12.2B5.0B5.0B6.2B5.0B16.3B8.2B9.0B1.0B0500M10.0B
Dividends per share1.721.721.691.651.611.571.531.461.381.281.201.121.040.960.880.800.72———
Free cash flow margin18.5%14.5%15.5%8.0%25.7%36.7%29.2%25.8%33.9%28.3%27.2%——31.9%28.2%30.4%15.3%31.2%34.2%23.7%